SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr | ₹33,498 Cr | ₹32,838 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Revenue |
---|---|
Mar2024 | ₹48,497 Cr |
Mar2023 | ₹43,886 Cr |
Mar2022 | ₹38,654 Cr |
Mar2021 | ₹33,498 Cr |
Mar2020 | ₹32,838 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹48,497 Cr | 10.51 | |
Mar2023 | ₹43,886 Cr | 13.53 | |
Mar2022 | ₹38,654 Cr | 15.39 | |
Mar2021 | ₹33,498 Cr | 2.01 | |
Mar2020 | ₹32,838 Cr | - |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹416,686.4 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
MANKIND PHARMA | ₹102,232.0 Cr | -5.9% | -14% | 21% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | -5.3% |
-7.8% |
24.1% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses